Pneumocystis jirovecii Colonization in Mexican Patients with Chronic Obstructive Pulmonary Disease

Marcela Plascencia-Cruz1,2, Arturo Plascencia-Hernández2,3, Yaxsier De Armas-Rodríguez4

  • 1Department of Internal Medicine, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Jalisco, Mexico.

Insights

Pneumocystis jirovecii colonization is common in Mexican COPD patients. Molecular detection via oropharyngeal wash and PCR offers a cost-effective method for future studies.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Epidemiology

Background:

  • Pneumocystis jirovecii (P. jirovecii) colonization prevalence is unestablished in Mexico.
  • Chronic Obstructive Pulmonary Disease (COPD) patients are a potential reservoir for P. jirovecii.
  • Understanding colonization is crucial for respiratory health management.

Purpose of the Study:

  • To determine P. jirovecii colonization prevalence in Mexican COPD patients.
  • To describe clinical and sociodemographic profiles of colonized and non-colonized patients.
  • To evaluate molecular detection methods for P. jirovecii in this population.

Main Methods:

  • Nested polymerase chain reaction (PCR) was used for molecular detection.
  • Oropharyngeal wash samples were collected from COPD patients at hospital discharge.
  • A cohort of 15 COPD patients without pneumonia was enrolled.

Main Results:

  • The prevalence of P. jirovecii colonization was 26.66% in the studied COPD population.
  • No significant clinical or sociodemographic differences were found between colonized and non-colonized groups.
  • Oropharyngeal wash and nested PCR proved effective for detection.

Conclusions:

  • P. jirovecii colonization is frequent in Mexican COPD patients.
  • The clinical significance of this colonization requires further investigation.
  • Oropharyngeal wash and nested PCR are viable, cost-effective methods for P. jirovecii detection in resource-limited settings.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
383
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K